Izabela Rumienczyk

6PUBLICATIONS
34CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical infection agents (incl. prions)Powder and particle technology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 13, 2026
Integrated Multi-Omics and Interactome Analysis of CDK8 Inhibition Reveals Erythroid Differentiation Programs and Therapeutic Synergy with BET Blockade in AML.

|Feb 13, 2026
Human Fecal Transplantation Modifies the Gut Microbiota but Not Metabolites in Colon Cancer Patient-Derived Xenografts.

Katarzyna Unrug-Bielawska, Zuzanna Sandowska-Markiewicz, Ewelina Kaniuga

|Jul 12, 2025
Comparative Analysis of Gut Microbiota Responses to New SN-38 Derivatives, Irinotecan, and FOLFOX in Mice Bearing Colorectal Cancer Patient-Derived Xenografts.

Katarzyna Unrug-Bielawska, Zuzanna Sandowska-Markiewicz, Magdalena Piątkowska

|Oct 13, 2021
Selective Extracellular Signal-Regulated Kinase 1/2 (ERK1/2) Inhibition by the SCH772984 Compound Attenuates In Vitro and In Vivo Inflammatory Responses and Prolongs Survival in Murine Sepsis Models.

Michal Kopczynski, Izabela Rumienczyk, Maria Kulecka

|Jun 11, 2021
Multi-Organ Transcriptome Dynamics in a Mouse Model of Cecal Ligation and Puncture-Induced Polymicrobial Sepsis.

Izabela Rumienczyk, Maria Kulecka, Jerzy Ostrowski

|Dec 02, 2019
Keratinocyte-specific ablation of Mcpip1 impairs skin integrity and promotes local and systemic inflammation.

Piotr Konieczny, Agata Lichawska-Cieslar, Patrycja Kwiecinska

Pageof 1

Frequent Collaborators

6 joint publications

Michal Mikula

2 joint publications

Paweł Czarnowski

2 joint publications

Aneta Bałabas

2 joint publications

Magdalena Piątkowska